---

---

tags : Treatment    symbols : ABT   

save search

---

FDA Rejects Abeona’s Gene Therapy, Approves ImmunityBio’s Bladder Cancer Treatment
Published: 2024-04-23 (Crawled : 13:30) - biospace.com/
PRGO | $31.23 2.43% 0.0% 960K |

Health Technology

| 3.89% | O: 0.13% H: 1.89% C: 1.3%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -0.13% | O: 0.89% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| -0.17% | O: 0.56% H: 0.41% C: -0.07%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 2.53% | O: 1.7% H: 0.0% C: 0.0%
fda bladder cancer treatment

---

Genentech’s ALK Inhibitor First Adjuvant Treatment for ALK-Positive, Early NSCLC
Published: 2024-04-19 (Crawled : 15:00) - biospace.com/
PRGO | $31.23 2.43% 0.0% 960K |

Health Technology

| 3.96% | O: -0.4% H: 3.01% C: 2.94%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| 2.2% | O: 0.83% H: 1.35% C: 1.2%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| 0.46% | O: -0.75% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 4.25% | O: 0.82% H: 0.0% C: 0.0%
first treatment for

---

Global Infectious Enteritis Treatment Market Report 2024: A USD$937.7 Million Market by 2034 - Antibiotics Segment Dominates the Market
Published: 2024-03-29 (Crawled : 23:00) - prnewswire.com
ARDX | $6.43 0.63% 0.62% 5.4M |

Health Technology

| Email alert Add to watchlist
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| Email alert Add to watchlist
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| Email alert Add to watchlist
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| Email alert Add to watchlist
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| Email alert Add to watchlist
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| Email alert Add to watchlist
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| Email alert Add to watchlist
report million treatment antibiotics global market

---

Regeneron Hit With Two CRLs, J&J’s PAH Treatment Approved
Published: 2024-03-25 (Crawled : 15:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| 0.3% | O: -100.0% H: NaN% C: Infinity%
PRGO | $31.23 2.43% 0.0% 960K |

Health Technology

| -0.29% | O: 0.35% H: 0.35% C: -1.34%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -4.77% | O: 0.04% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| -3.33% | O: -0.07% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -1.3% | O: 0.42% H: 0.0% C: 0.0%
approved treatment

---

Chemotherapy Induced Peripheral Neuropathy Treatment Market Projected Strong Growth to $2.25 Billion by 2028 Amid Advancements in Cancer Treatment
Published: 2024-03-07 (Crawled : 00:00) - prnewswire.com
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| -9.74% | O: 1.41% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 0.23% | O: 1.62% H: 0.0% C: 0.0%
QDEL | News 4 | $40.81 1.02% 1.0% 940K |

Health Technology

| -4.78% | O: 1.14% H: 4.36% C: 3.16%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| -1.29% | O: -0.1% H: 0.18% C: -1.25%
cancer treatment growth market

---

FDA Decisions: J&J’s Rybrevant Becomes First Front-Line Treatment for Type of NSCLC
Published: 2024-03-04 (Crawled : 14:30) - biospace.com/
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| -0.53% | O: -0.9% H: 0.0% C: 0.0%
PRGO | $31.23 2.43% 0.0% 960K |

Health Technology

| 18.61% | O: 0.65% H: 1.13% C: -1.02%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -8.46% | O: -0.42% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| -9.78% | O: 0.03% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 0.14% | O: -0.8% H: 0.0% C: 0.0%
fda first treatment rybrevant

---

FDA Decisions: First Frontline Pancreatic Cancer Treatment Approved in More t...
Published: 2024-02-15 (Crawled : 17:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| 3.92% | O: 1.16% H: 1.48% C: 0.89%
PRGO | $31.23 2.43% 0.0% 960K |

Health Technology

| -1.05% | O: 0.67% H: 2.06% C: 1.86%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -5.2% | O: -0.19% H: 1.6% C: 1.24%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| -4.61% | O: 0.41% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 3.91% | O: 1.86% H: 0.0% C: 0.0%
fda first approved cancer pancreatic treatment

---

FDA Decisions: First Frontline Pancreatic Cancer Treatment Approved in More than a Decade
Published: 2024-02-15 (Crawled : 17:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| 3.92% | O: 1.16% H: 1.48% C: 0.89%
PRGO | $31.23 2.43% 0.0% 960K |

Health Technology

| -1.05% | O: 0.67% H: 2.06% C: 1.86%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -5.2% | O: -0.19% H: 1.6% C: 1.24%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| -4.61% | O: 0.41% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 3.91% | O: 1.86% H: 0.0% C: 0.0%
fda first approved cancer pancreatic treatment

---

Sinusitis Treatment Market Global Trends, Opportunity, and Forecast, 2018-2028F - Increasing Patient Preference for Minimally Invasive Procedures
Published: 2024-02-13 (Crawled : 04:00) - prnewswire.com
SYK | $336.85 0.58% 0.0% 1.5M |

Health Technology

| -1.24% | O: -0.35% H: 0.41% C: -0.03%
MDT | $80.38 -1.12% 0.0% 5M |

Health Technology

| -5.51% | O: -0.59% H: 0.51% C: -1.16%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| -4.16% | O: 0.94% H: 0.0% C: 0.0%
treatment global sinusitis market

---

FDA Decisions: Agency Greenlights Takeda's Oral EoE Treatment in Company's Se...
Published: 2024-02-12 (Crawled : 17:00) - biospace.com/
PRGO | $31.23 2.43% 0.0% 960K |

Health Technology

| -2.04% | O: 0.31% H: 1.44% C: 1.31%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -5.01% | O: 0.41% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| -4.78% | O: -0.64% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 1.81% | O: -0.86% H: 0.0% C: 0.0%
fda treatment

---

Global Epidural Abscess Treatment Market Report 2024 - Treatment Advances and Digital Health Technologies Shaping the Future of Epidural Abscess Care
Published: 2024-02-12 (Crawled : 15:30) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| 9.6% | O: -0.57% H: 0.04% C: -1.74%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| -2.65% | O: -1.46% H: 1.04% C: 0.97%
LLY | News | $732.2 -1.81% 0.18% 2.1M |

Health Technology

| 1.63% | O: 0.09% H: 0.0% C: -0.48%
BMY | $48.86 -0.27% -0.02% 16M |

Health Technology

| -1.91% | O: 0.02% H: 0.46% C: -0.14%
ABBV | News | $167.8 -1.03% -0.06% 4.1M |

Health Technology

| -4.11% | O: -0.83% H: 0.7% C: -0.27%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| -4.78% | O: -0.64% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 1.81% | O: -0.86% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 14.36% | O: -1.77% H: 0.46% C: 0.41%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| -6.22% | O: -0.4% H: 1.6% C: 1.54%
report health treatment care global market

---

FDA Decisions: Agency Greenlights Takeda's Oral EoE Treatment in Company's Second Straight Win
Published: 2024-02-12 (Crawled : 15:00) - biospace.com/
PRGO | $31.23 2.43% 0.0% 960K |

Health Technology

| -2.04% | O: 0.31% H: 1.44% C: 1.31%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -5.01% | O: 0.41% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| -4.78% | O: -0.64% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 1.81% | O: -0.86% H: 0.0% C: 0.0%
fda treatment

---

Global Pseudomonas Aeruginosa Infection Treatment Market Report 2024-2034: Rising Antibiotic Resistance Drives Demand for Pseudomonas Aeruginosa Infection Treatments
Published: 2024-01-17 (Crawled : 02:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 1.33% | O: -0.56% H: 0.0% C: 0.0%
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| -9.53% | O: -1.83% H: 0.0% C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| -8.67% | O: 0.49% H: 0.18% C: 0.04%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -8.51% | O: -1.02% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 2.46% | O: -0.08% H: 0.1% C: -0.18%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| -5.81% | O: 0.12% H: 0.77% C: 0.27%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -8.18% | O: 0.45% H: 0.06% C: -0.5%
GILD | $67.07 0.06% 0.06% 8.3M |

Health Technology

| -21.99% | O: -0.19% H: 0.87% C: 0.76%
report infection treatment global market

---

Global Atherectomy Devices Market Report 2023-2030: Minimally Invasive Treatment Options Surge in Demand, Key Players Boston Scientific, Abbott, and Medtronic Shape the Landscape
Published: 2024-01-09 (Crawled : 01:00) - prnewswire.com
TRUMF | $16.608 -17.59% 5.6K |

Health Technology

| -48.91% | O: 0.63% H: 0.0% C: 0.0%
TRUMY | $17.05 0.79% 47K |

Manufacturing

| -47.96% | O: 4.99% H: 0.29% C: -2.67%
MDT | $80.38 -1.12% 0.0% 5M |

Health Technology

| -7.15% | O: -0.16% H: 1.86% C: 0.27%
ITGR | $123.27 4.55% 1.7% 1.1M |

Producer Manufacturing

| 24.18% | O: -1.35% H: 2.08% C: 1.1%
BSX | $72.91 5.68% -0.03% 15M |

Health Technology

| 24.8% | O: -0.38% H: 2.06% C: 1.77%
BDX | $233.83 -0.23% 3.49% 780K |

Health Technology

| -5.61% | O: -0.22% H: 1.1% C: -3.78%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| -3.8% | O: 1.04% H: 0.0% C: 0.0%
report treatment global key market

---

FDA Decisions: AstraZeneca and Ionis Gain Approval for Self-Administered hATTR-PN Treatment
Published: 2023-12-22 (Crawled : 14:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| -1.89% | O: 3.66% H: 0.0% C: -0.12%
PRGO | $31.23 2.43% 0.0% 960K |

Health Technology

| -0.57% | O: -0.06% H: 1.21% C: 0.99%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -3.5% | O: 1.09% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| -0.34% | O: 1.52% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -2.64% | O: 1.03% H: 0.0% C: 0.0%
fda approval astrazeneca treatment

---

Global Progressive Ataxia and Weakness Disorders Treatment Market Report: Focus on Key Players Novartis, Pfizer, Sanofi, GlaxoSmithKline, Roche, Merck, Takeda Pharmaceuticals and Abbott Laboratories
Published: 2023-12-19 (Crawled : 19:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| -2.05% | O: -0.39% H: 1.49% C: 0.32%
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| -0.52% | O: 0.8% H: 0.0% C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 0.06% | O: -0.15% H: 0.27% C: -1.02%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -4.61% | O: 0.73% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| -1.08% | O: 0.01% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -2.52% | O: 0.21% H: 0.0% C: 0.0%
disorders treatment pharmaceuticals global market

---

Acute Ischemic Stroke Diagnosis and Treatment Market to Reach $9.2 Billion, Globally, by 2032 at 6.1% CAGR: Allied Market Research
Published: 2023-12-14 (Crawled : 01:00) - prnewswire.com
FNCTF | News | $11.16 -20.84% 130 |

Communications

| -6.3% | O: -1.89% H: 0.0% C: 0.0%
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| 4.71% | O: 1.19% H: 3.09% C: 1.3%
SYK | $336.85 0.58% 0.0% 1.5M |

Health Technology

| 12.84% | O: 0.16% H: 0.52% C: -0.64%
MDT | $80.38 -1.12% 0.0% 5M |

Health Technology

| -1.86% | O: 1.05% H: 2.38% C: 0.81%
PHG | News | $20.97 -0.19% 0.0% 650K |

Health Technology

| 0.05% | O: 4.96% H: 1.5% C: 0.91%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -3.65% | O: 1.81% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| 0.9% | O: 1.78% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 8.04% | O: 1.21% H: 0.27% C: -0.52%
stroke reach treatment research market

---

FDA Decisions: First Treatment for Desmoid Tumors and a Dry Eye Rejection for Aldeyra
Published: 2023-11-28 (Crawled : 15:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| -0.91% | O: -1.89% H: 0.02% C: 0.02%
PRGO | $31.23 2.43% 0.0% 960K |

Health Technology

| 1.56% | O: 0.78% H: 0.81% C: -1.71%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -2.08% | O: 0.09% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| 4.07% | O: -0.24% H: 0.03% C: -0.39%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -0.43% | O: -1.41% H: 0.87% C: 0.0%
fda tumors treatment eye

---

Nutraceuticals Market to grow by USD 223.56 billion from 2022 to 2027 | The increasing cost of medical treatment to drive market growth - Technavio
Published: 2023-11-24 (Crawled : 10:00) - prnewswire.com
WMT | News | $59.87 1.32% -0.23% 19M |

Retail Trade

| 16.12% | O: 0.31% H: 0.63% C: 0.59%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| 4.28% | O: 0.3% H: 0.0% C: 0.0%
treatment medical growth market

---

Global Thyroid Gland Disorder Treatment Market Set to Reach USD 3.15 Billion by 2030, Reveals Infinium Global Research
Published: 2023-11-03 (Crawled : 09:00) - prnewswire.com
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| 2.95% | O: -1.88% H: 3.51% C: 2.73%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 4.54% | O: -1.4% H: 0.42% C: 0.0%
ABBV | News | $167.8 -1.03% -0.06% 4.1M |

Health Technology

| 18.8% | O: 1.88% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| 12.41% | O: 2.0% H: 0.0% C: 0.0%
reach treatment thyroid research global set market

---

Gainers vs Losers

62%

38%

Top 10 Gainers

CSSE 4 | $0.4323 183.85% 64.77% 220M |

Consumer Services

BOF | $1.99 70.09% 41.21% 110M |

ILAG | $0.51 6.03% 40.62% 1.7M |

LICN | $0.941 68.04% 40.49% 15M |

AMST | $3.31 65.5% 39.58% 70M |

Technology Services

MTC | $3.615 61.38% 38.04% 9.3M |

Technology Services

WIMI | $1.15 58.53% 36.92% 19M |

Technology Services

AIH | $0.45 12.5% 30.92% 320K |

Health Services

MULN | News | $3.78 38.46% 27.78% 13M |

Information

RILY | $29.86 37.48% 27.26% 12M |

Finance

---

Your saved searches

---